awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33417869-0EFA0AD5-0425-4FA1-AEE7-132917DEA046
Q33417869-0EFA0AD5-0425-4FA1-AEE7-132917DEA046
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33417869-0EFA0AD5-0425-4FA1-AEE7-132917DEA046
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.
P2860
Q33417869-0EFA0AD5-0425-4FA1-AEE7-132917DEA046
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33417869-0EFA0AD5-0425-4FA1-AEE7-132917DEA046
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
436f89f04d30e0f1d9bdab1e5a92f5615b749d07
P2860
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study.